Cargando…

Development of an Immune-Related Risk Signature in Patients with Bladder Urothelial Carcinoma

With recent advances in immunooncology and tumor microenvironment, the treatment landscape of bladder urothelial carcinoma has been changing dramatically. We aim to construct an immune gene-related signature which can predict BLCA patients' overall survival. Transcriptomic data of BLCA patients...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Yaofei, Wang, Yibing, Li, Cong, Zou, Zhenhong, Liang, Bo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2020
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7455840/ https://www.ncbi.nlm.nih.gov/pubmed/32884943 http://dx.doi.org/10.1155/2020/5848493

Ejemplares similares

Immune Signature-Based Risk Stratification and Prediction of Immunotherapy Efficacy for Bladder Urothelial Carcinoma
por: Liang, Fangfang, et al.
Publicado: (2021)

Construction and validation of a gene signature related to bladder urothelial carcinoma based on immune gene analysis
por: Xing, Peng, et al.
Publicado: (2022)

Identification of tryptophan metabolism- and immune-related genes signature and prediction of immune infiltration landscape in bladder urothelial carcinoma
por: Zhou, Guanwen, et al.
Publicado: (2023)

A novel cuproptosis-related lncRNAs signature predicts prognostic and immune of bladder urothelial carcinoma
por: Zhou, Zheng, et al.
Publicado: (2023)

Identification of a basement membrane-related genes signature with immune correlation in bladder urothelial carcinoma and verification in vitro
por: Li, Yanze, et al.
Publicado: (2023)

A Necroptosis-Related lncRNA to Develop a Signature to Predict the Outcome, Immune Landscape, and Chemotherapeutic Responses in Bladder Urothelial Carcinoma
por: Hou, Jian, et al.
Publicado: (2022)

Comprehensive analysis of cuproptosis-related lncRNAs signature to predict prognosis in bladder urothelial carcinoma
por: Zhu, Shusheng, et al.
Publicado: (2023)

An eight-mRNA signature predicts the prognosis of patients with bladder urothelial carcinoma
por: Zhu, Rui, et al.
Publicado: (2019)

MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022)

Identification of Prognostic Immune Genes in Bladder Urothelial Carcinoma
por: Su, Qisheng, et al.
Publicado: (2020)

A novel signature constructed by ferroptosis-associated genes (FAGs) for the prediction of prognosis in bladder urothelial carcinoma (BLCA) and associated with immune infiltration
por: Luan, Jiao-chen, et al.
Publicado: (2021)

Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma
por: Luo, Qizhan, et al.
Publicado: (2020)

Identification of 9-Core Immune-Related Genes in Bladder Urothelial Carcinoma Prognosis
por: Na, Lei, et al.
Publicado: (2020)

Integrated Analysis of Energy Metabolism Signature-Identified Distinct Subtypes of Bladder Urothelial Carcinoma
por: Zhang, Fan, et al.
Publicado: (2022)

Prediction of immune infiltration and prognosis for patients with urothelial bladder cancer based on the DNA damage repair-related genes signature
por: Li, Tianhang, et al.
Publicado: (2023)

The clonal relation of primary upper urinary tract urothelial carcinoma and paired urothelial carcinoma of the bladder
por: van Doeveren, Thomas, et al.
Publicado: (2020)

Identification of a Novel Tumor Microenvironment Prognostic Signature for Bladder Urothelial Carcinoma
por: Xu, Chaojie, et al.
Publicado: (2022)

A prognostic signature based on seven T-cell-related cell clustering genes in bladder urothelial carcinoma
por: Yang, Jie, et al.
Publicado: (2023)

Corrigendum to “Construction of Protein-related Risk Score Model in Bladder Urothelial Carcinoma”
por: Luo, Qizhan, et al.
Publicado: (2021)

Long-Term Outcomes of Radical Surgery for Transverse Colon Cancer Staged from I to IIIC
por: Jiang, Yaofei, et al.
Publicado: (2020)

The G protein-coupled receptor-related gene signatures for predicting prognosis and immunotherapy response in bladder urothelial carcinoma
por: Wan, Zhengqiang, et al.
Publicado: (2023)

Establishment of a risk score model for bladder urothelial carcinoma based on energy metabolism‐related genes and their relationships with immune infiltration
por: Huang, Caihong, et al.
Publicado: (2023)

Genome-Wide Analyses of Prognostic and Therapeutic Alternative Splicing Signatures in Bladder Urothelial Carcinoma
por: Fan, Zhongru, et al.
Publicado: (2021)

A new m(6)A methylation-related gene signature for prognostic value in patient with urothelial carcinoma of the bladder
por: Zheng, Bin, et al.
Publicado: (2021)

A Novel Prognostic Signature Based on Ferroptosis-Related Genes Predicts the Prognosis of Patients With Advanced Bladder Urothelial Carcinoma
por: Li, Xiaoqi, et al.
Publicado: (2021)

A potential prognostic lncRNA signature for predicting survival in patients with bladder urothelial carcinoma
por: Bao, Zhenyu, et al.
Publicado: (2017)

Author Correction: MicroRNA signature for estimating the survival time in patients with bladder urothelial carcinoma
por: Yerukala Sathipati, Srinivasulu, et al.
Publicado: (2022)

Sex-related differences in urothelial cell carcinoma of the bladder in Germany
por: Scheller, Thomas, et al.
Publicado: (2018)

Prognosis and immune infiltration analysis of endoplasmic reticulum stress-related genes in bladder urothelial carcinoma
por: Wang, Yaxuan, et al.
Publicado: (2022)

Intravesical therapy for urothelial carcinoma of the bladder
por: Manoharan, M.
Publicado: (2011)

Role of angiogenesis in urothelial bladder carcinoma
por: Fus, Łukasz Piotr, et al.
Publicado: (2016)

Bladder melanosis with concurrent urothelial carcinoma
por: Yau, Susanna E., et al.
Publicado: (2017)

Cutaneous metastasis of bladder urothelial carcinoma
por: Hasan, Osamah, et al.
Publicado: (2019)

Giant Cell Urothelial Carcinoma of Bladder
por: Wijesinghe, Harshima Disvini, et al.
Publicado: (2021)

Molecular classification of urothelial bladder carcinoma
por: Schwarzova, Lucia, et al.
Publicado: (2023)

Prognostic model of 10 immune-related genes and identification of small molecule drugs in bladder urothelial carcinoma (BLCA)
por: Xing, Qianwei, et al.
Publicado: (2020)

Advances in the Management of Patients With Urothelial Carcinomas of the Bladder
por: Shah, Amishi, et al.
Publicado: (2018)

Identification and functional analysis of risk-related microRNAs for the prognosis of patients with bladder urothelial carcinoma
por: Gao, Ji, et al.
Publicado: (2017)

MLKL and other necroptosis-related genes promote the tumor immune cell infiltration, guiding for the administration of immunotherapy in bladder urothelial carcinoma
por: Zhong, Boqiang, et al.
Publicado: (2023)

Derivation and external validation of dendritic cell-related gene signatures for predicting prognosis and immunotherapy efficacy in bladder urothelial carcinoma
por: An, Bingzheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_54a6hpl73cfjfgbhaeq1ogasqr